← Back to Search

Omega-3 Fatty Acid Supplement

EPA/DHA Supplements for Healthy Eating

Phase < 1
Recruiting
Led By Yael Vodovotz, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study if an algae oil-fortified soymilk is as effective as a commercial algae oil capsule in increasing EPA and DHA in the blood.

Who is the study for?
This trial is for adults with a BMI between 18 and 30 who are not pregnant or nursing, don't have anemia, high cholesterol/triglycerides, coagulation disorders, diabetes, allergies to ingredients in the test products, and haven't taken omega-3 supplements or certain medications recently.
What is being tested?
The study aims to compare how well the body absorbs EPA and DHA (healthy fats) from algae oil fortified soymilk versus standard algae oil capsules. It will measure the levels of these fats in participants' blood over time.
What are the potential side effects?
Since this trial involves healthy eating interventions with soymilk and capsules containing natural oils, side effects might be minimal but could include digestive discomfort or allergic reactions if sensitivity to ingredients exists.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Erythrocyte EPA and DHA levels
Secondary study objectives
Peripheral blood mononuclear cell (PBMC) EPA and DHA levels
Plasma EPA and DHA levels
Other study objectives
Compliance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Algae Oil Fortified SoymilkExperimental Treatment1 Intervention
Subjects will drink 12 ounces of 0.4% algae oil-fortified soymilk
Group II: Algae Oil SupplementsActive Control1 Intervention
Subjects will take 2 commercial algae oil capsules.

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
342 Previous Clinical Trials
293,183 Total Patients Enrolled
Yael Vodovotz, PhDPrincipal InvestigatorOhio State University
~5 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top